Literature DB >> 18487576

Rituximab-induced hepatitis C virus reactivation after spontaneous remission in diffuse large B-cell lymphoma.

Ching-Yun Hsieh1, Hsin-Hui Huang, Chen-Yuan Lin, Lo Woei Chung, Yu-Mine Liao, Li-Yuan Bai, Chang-Fang Chiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18487576     DOI： 10.1200/JCO.2007.15.4807

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

2.  Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi.

Authors:  Michele Merli; Carlo Visco; Michele Spina; Stefano Luminari; Virginia Valeria Ferretti; Manuel Gotti; Sara Rattotti; Valeria Fiaccadori; Chiara Rusconi; Clara Targhetta; Caterina Stelitano; Alessandro Levis; Achille Ambrosetti; Davide Rossi; Luigi Rigacci; Alfonso Maria D'Arco; Pellegrino Musto; Annalisa Chiappella; Luca Baldini; Maurizio Bonfichi; Luca Arcaini
Journal:  Haematologica       Date:  2013-11-22       Impact factor: 9.941

3.  Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Shiv Kumar Sarin; Ashish Kumar; John A Almeida; Yogesh Kumar Chawla; Sheung Tat Fan; Hitendra Garg; H Janaka de Silva; Saeed Sadiq Hamid; Rajiv Jalan; Piyawat Komolmit; George K Lau; Qing Liu; Kaushal Madan; Rosmawati Mohamed; Qin Ning; Salimur Rahman; Archana Rastogi; Stephen M Riordan; Puja Sakhuja; Didier Samuel; Samir Shah; Barjesh Chander Sharma; Praveen Sharma; Yasuhiro Takikawa; Babu Ram Thapa; Chun-Tao Wai; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2008-11-20       Impact factor: 6.047

4.  The safety of chemotherapy for colorectal cancer patients with hepatitis C virus infection.

Authors:  Kenji Tomizawa; Koichi Suyama; Shuichiro Matoba; Yutaka Hanaoka; Shigeo Toda; Jin Moriyama; Akihiko Shimomura; Yuji Miura; Hiromitsu Kumada; Hiroya Kuroyanagi; Toshimi Takano
Journal:  Med Oncol       Date:  2014-09-20       Impact factor: 3.064

Review 5.  Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatment.

Authors:  Carlo Visco; Silvia Finotto
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

7.  'Les liaisons dangereuses': Hepatitis C, Rituximab and B-cell non-Hodgkin's lymphomas.

Authors:  Massimo Marignani; Michela di Fonzo; Paola Begini; Elia Gigante; Ilaria Deli; Adriano M Pellicelli; Sara Gallina; Emanuela de Santis; Gianfranco Delle Fave; M Christina Cox
Journal:  World J Gastrointest Pharmacol Ther       Date:  2012-04-06

8.  The safety of chemotherapy for breast cancer patients with hepatitis C virus infection.

Authors:  Yuji Miura; Richard L Theriault; Yoichi Naito; Koichi Suyama; Akihiko Shimomura; Tsuguo Iwatani; Daishu Miura; Hidetaka Kawabata; Hiromitsu Kumada; Toshimi Takano
Journal:  J Cancer       Date:  2013-07-24       Impact factor: 4.207

Review 9.  Benign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus Infection.

Authors:  Shiksha Kedia; Vijaya Raj Bhatt; Sandeep Kumar Rajan; Pavan Kumar Tandra; Radwa A El Behery; Mojtaba Akhtari
Journal:  Int J Prev Med       Date:  2014-12

Review 10.  Rituximab-based treatment, HCV replication, and hepatic flares.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Caterina Sagnelli; Nicola Coppola
Journal:  Clin Dev Immunol       Date:  2012-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.